1/15/25 17:00 | 1/13/25 | RGLS | Regulus Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | DO | P,Head o | S | -40 | 1.26 | 0 | -31 | -47 | 36 | D | | | | | | | | | | | | | | |
1/27/23 16:42 | 1/26/23 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | DO | P,CEO | S | -157 | 0.4132 | 0 | -381 | -41 | 542 | D | | | | | | | | | | | | | | |
4/20/22 16:25 | 4/19/22 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | DO | P,CEO | S | -22 | 0.5022 | 0 | -45 | -5 | 923 | D | | | | | | | | | | | | | | |
5/20/21 18:55 | 5/20/21 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | DO | P,CEO | P | 75 | 3.64 | 0 | 21 | New | 21 | D | | | | | | | | | | | | | | |
10/16/19 20:20 | 10/14/19 | ARNA | Arena Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | O | EVP,CMO | M.d | 0 | 0.00 | 0 | 6 | | 4 | D | | | | | | | | | | | | | | |
1/8/19 21:04 | 1/7/19 | ARNA | Arena Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | O | EVP,CMO | M.dm | 287 | 15.10 | 0 | 19 | | 0 | D | | | | | | | | | | | | | | |
1/8/19 21:04 | 1/7/19 | ARNA | Arena Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | O | EVP,CMO | S.dm | -799 | 42.06 | 0 | -19 | -100 | 0 | D | | | | | | | | | | | | | | |
7/29/13 19:49 | 7/25/13 | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | O | SVP,Head | M.d | 118 | 1.66 | 1 | 71 | | 0 | D | 349 | 32 | 29 | 18 | 18 | 23 | 20 | 13 | 0 | -1 | -5 | -28 | -13 | -34 |
7/29/13 19:49 | 7/25/13 | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | O | SVP,Head | S.d | -510 | 7.16 | 1 | -71 | -100 | 0 | D | 349 | 32 | 29 | 18 | 18 | 23 | 20 | 13 | 0 | -1 | -5 | -28 | -13 | -34 |
5/30/13 17:38 | 5/28/13 | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | O | SVP,Head | M.d | 48 | 1.66 | 1 | 29 | | 0 | D | 127 | 87 | 31 | 18 | 3 | 7 | 6 | -1 | -3 | -7 | -8 | 3 | -5 | -1 |
5/30/13 17:38 | 5/28/13 | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klassen Preston | CA | O | SVP,Head | S.d | -207 | 7.21 | 1 | -29 | -100 | 0 | D | 127 | 87 | 31 | 18 | 3 | 7 | 6 | -1 | -3 | -7 | -8 | 3 | -5 | -1 |